Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00815074 · ClinicalTrials.gov registry record

Military Women's Health and Illness Behaviors in Deployed Settings

A clinical trial, sponsored by 59th Medical Wing.

Completed
Registry status
44
Enrollment target

NCT00815074: Completed study, sponsored by 59th Medical Wing.

NCT00815074 is a clinical trial that has completed, run by 59th Medical Wing. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00815074 has completed, sponsored by 59th Medical Wing.

COMPLETED
Registry status
44 participants
Enrollment target

Study Summary

The purpose of this study is to gain better understanding of how recently deployed military women managed urinary and vaginal symptoms while deployed. Participants in this study will be asked to take part in a 45-60 minute interview.

Primary Outcome

interview data analysis

Interventions

  • OTHER No intervention

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2008-12-15
Est. Completion 2011-12-15
59th Medical Wing

20 total trials

What the finished NCT00815074 record still lists

NCT00815074 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.

NCT00815074 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00815074 about?

NCT00815074 is a clinical study titled "Military Women's Health and Illness Behaviors in Deployed Settings". The purpose of this study is to gain better understanding of how recently deployed military women managed urinary and vaginal symptoms while deployed. Participants in this study will be asked to take part in a 45-60 minute interview.

What is the current status of trial NCT00815074?

This trial is currently completed. The enrollment target is 44 participants. The study started on 2008-12-15. Estimated completion is 2011-12-15.

What interventions are being tested in trial NCT00815074?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT00815074?

This trial is sponsored by 59th Medical Wing, which has 20 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00815074, the US trial registry maintained by the National Library of Medicine. NCT00815074 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.